The gut microbiota of alpha-synuclein-overexpressing mice (a model of Parkinson’s Disease) promotes motor dysfunction and neuroinflammation, while antibiotic treatment ameliorates the pathophysiology in animals, revealing that postnatal signaling between the gut and the brain modulates this disease (Sampson et al., 2016). Here, SNCA is linked to Parkinson disease.